Fei Yin

432 total citations
28 papers, 265 citations indexed

About

Fei Yin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Fei Yin has authored 28 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Fei Yin's work include Pancreatic and Hepatic Oncology Research (4 papers), Gastric Cancer Management and Outcomes (4 papers) and RNA modifications and cancer (4 papers). Fei Yin is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Gastric Cancer Management and Outcomes (4 papers) and RNA modifications and cancer (4 papers). Fei Yin collaborates with scholars based in China, United States and United Kingdom. Fei Yin's co-authors include Jianfei Shi, Xiaolei Yin, Man Zhao, Jinfeng Wang, Shukun Yao, Ruliang Xu, Fei Ye, Bo Jiang, David Y. Zhang and David Burstein and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal Of Pathology.

In The Last Decade

Fei Yin

27 papers receiving 261 citations

Peers

Fei Yin
Hao Zeng China
Xufeng Lu China
Haojiang Dai China
Rui Cong China
Santo Colosimo Italy
John C. Rhee United States
Wenxin Wei China
Zhili Wen China
Anrong Mao China
Yamin Zhang China
Hao Zeng China
Fei Yin
Citations per year, relative to Fei Yin Fei Yin (= 1×) peers Hao Zeng

Countries citing papers authored by Fei Yin

Since Specialization
Citations

This map shows the geographic impact of Fei Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Yin more than expected).

Fields of papers citing papers by Fei Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Yin. The network helps show where Fei Yin may publish in the future.

Co-authorship network of co-authors of Fei Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Yin. A scholar is included among the top collaborators of Fei Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Yin. Fei Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jinfeng, Xiaoxiao Wang, Jianfei Shi, et al.. (2025). CD161, a promising prognostic biomarker in hepatocellular carcinoma, correlates with immune infiltration. PeerJ. 13. e19055–e19055.
2.
Liang, Limin, et al.. (2025). A novel high-oxygen-evolution anode boosts microbial electrolysis for perfluorooctanoic acid removal. Desalination and Water Treatment. 323. 101291–101291. 1 indexed citations
3.
Yin, Fei, et al.. (2025). Immune cell senescence in autoimmunity: implications for disease pathogenesis and therapeutic targeting. Frontiers in Immunology. 16. 1596686–1596686. 1 indexed citations
4.
Yin, Fei, Li‐Tang Qin, Yabin Li, et al.. (2025). Efficient degradation of chloridazon based on Ni-MHOF electrocatalytic anode. Journal of environmental chemical engineering. 13(3). 116734–116734. 3 indexed citations
5.
6.
Zhao, Man, Xiaolei Yin, Jianfei Shi, et al.. (2023). Molecular typing and mutational characterization of rectal neuroendocrine neoplasms. Cancer Medicine. 12(15). 16207–16220. 6 indexed citations
7.
Wu, Jian, et al.. (2023). Dicer Suppresses Hepatocellular Carcinoma via Interleukin-8 Pathway. Clinical Medicine Insights Oncology. 17. 1373282172–1373282172. 1 indexed citations
8.
Zhao, Man, Jinfeng Wang, Jianfei Shi, et al.. (2022). Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells. Frontiers in Oncology. 12. 854096–854096. 34 indexed citations
9.
10.
Sun, Xia, Liqi Liu, Fei Yin, et al.. (2020). Label-free amplified fluorescence detection of DNA biomarkers based on KFP polymerase-driven double strand displacement reactions and magnetic nanoprobes. Analytical Methods. 12(24). 3092–3097. 3 indexed citations
11.
Shi, Jianfei, Jinfeng Wang, Man Zhao, et al.. (2020). Matrine promotes hepatic oval cells differentiation into hepatocytes and alleviates liver injury by suppression of Notch signalling pathway. Life Sciences. 261. 118354–118354. 13 indexed citations
12.
Zhao, Man, Shenglei Zhang, Zhibin Xu, et al.. (2020). Effects of tumor distance from anal verge on survival outcomes for rectal NENs and lymphatic metastasis risk score for colorectal NENs. International Journal of Colorectal Disease. 35(7). 1255–1264. 7 indexed citations
13.
14.
Liu, Liqi, Fei Yin, Yu Lu, et al.. (2020). A light-up “G-quadruplex nanostring” for label-free and selective detection of miRNA via duplex-specific nuclease mediated tandem rolling circle amplification. Nanomedicine Nanotechnology Biology and Medicine. 32. 102339–102339. 13 indexed citations
15.
Shi, Jianfei, Jinfeng Wang, Man Zhao, et al.. (2019). Matrine prevents the early development of hepatocellular carcinoma like lesions in rat liver. Experimental and Therapeutic Medicine. 18(4). 2583–2591. 14 indexed citations
16.
17.
Yin, Fei, et al.. (2017). Mutations in hepatitis B virus polymerase are associated with the postoperative survival of hepatocellular carcinoma patients. PLoS ONE. 12(12). e0189730–e0189730. 15 indexed citations
18.
Yin, Fei, et al.. (2016). Importance of SALL4 in the development and prognosis of hepatocellular carcinoma. World Journal of Gastroenterology. 22(9). 2837–2837. 27 indexed citations
19.
Ye, Fei, Ruliang Xu, Haitao Qing, et al.. (2012). Co-Expression of XIAP and Cyclin D1 Complex Correlates with a Poor Prognosis in Patients with Hepatocellular Carcinoma. American Journal Of Pathology. 180(5). 1798–1807. 46 indexed citations
20.
Liu, Juan, Shukun Yao, & Fei Yin. (2008). [Expression and significance of minichromosome maintenance protein7 in hepatocellular carcinoma].. PubMed. 16(1). 55–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hao Zeng Breakdown of academic impact, for papers by Xufeng Lu Breakdown of academic impact, for papers by Haojiang Dai Breakdown of academic impact, for papers by Rui Cong Breakdown of academic impact, for papers by Santo Colosimo Breakdown of academic impact, for papers by John C. Rhee Breakdown of academic impact, for papers by Wenxin Wei Breakdown of academic impact, for papers by Zhili Wen Breakdown of academic impact, for papers by Anrong Mao Breakdown of academic impact, for papers by Yamin Zhang
Rankless by CCL
2026